Clal Biotechnology Fundamental Relationships

CBI -- Israel Stock  

ILS 288.20  3.40  1.17%

The Drivers Module shows relationships between Clal Biotechnology's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Clal Biotechnology Industries Ltd over time as well as its relative position and ranking within its peers. Check also Trending Equities.

Clal Biotechnology Number of Employees vs. Beta Fundamental Analysis

Clal Biotechnology Industries Ltd is rated second in beta category among related companies. It is rated third in number of employees category among related companies creating about  12.96  of Number of Employees per Beta.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of financial instrument to the financial market in which this instrument is traded. For example if Beta of equity is 2, it will be expected to significantly outperform market when market is going up and significantly underperform when market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns during over time.
Clal Biotechnology 
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Number of Employees shows total number of permanent full time and part time employees working for a given company and processed through its payroll.
Clal Biotechnology 
Number of Employees 
Full Time 
Part Time 
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Clal Biotechnology Industries Ltd is rated third in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 523. Clal Biotechnology holds roughly 14.0 in number of employees claiming about 2.68% of stocks in Biotechnology industry.
      Chicago Bridge Comparables 
Clal Biotechnology is currently under evaluation in revenue category among related companies.